ScholarIQanswers from OpenAlex
Randomized phase 2 trial of NP001, a novel immune regulator
PaperCitations, authors & open-access status
Randomized phase 2 trial of NP001, a novel immune regulator is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Randomized phase 2 trial of NP001, a novel immune regulator have?
ScholarIQcitation count
Randomized phase 2 trial of NP001, a novel immune regulator has 98 citations in the OpenAlex counts ScholarIQ stores.
When was Randomized phase 2 trial of NP001, a novel immune regulator published?
ScholarIQyear
Randomized phase 2 trial of NP001, a novel immune regulator has 2015 year in the ScholarIQ index.
What is the open-access status of Randomized phase 2 trial of NP001, a novel immune regulator?
ScholarIQoa status
Randomized phase 2 trial of NP001, a novel immune regulator has gold oa status in the ScholarIQ index.
What is the DOI of Randomized phase 2 trial of NP001, a novel immune regulator?
ScholarIQdoi
The DOI for Randomized phase 2 trial of NP001, a novel immune regulator is on the source record.
What is the PMID of Randomized phase 2 trial of NP001, a novel immune regulator?
ScholarIQpmid
The PMID for Randomized phase 2 trial of NP001, a novel immune regulator is on the source record.
What is the OpenAlex record for Randomized phase 2 trial of NP001, a novel immune regulator?
ScholarIQopenalex
The OpenAlex for Randomized phase 2 trial of NP001, a novel immune regulator is on the source record.